Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 14

It’s not just deep sleep: Anesthesia drives brain into a strange state doctors are only beginning to map

People often describe anesthesia as something that puts a patient in a “deep sleep.” An anesthesiologist enters the operating room, and part of their mission is to ensure that the patient is completely unaware of what is happening around them until they wake up, often several hours later. Scientists and doctors have long debated what happens to the brain under anesthetic drugs during a surgical procedure.

A new study by Yale School of Medicine’s Departments of Anesthesiology and Neurology published on May 11, 2026, in Proceedings of the National Academy of Sciences uncovers new insights which may change the way we describe being under anesthesia. The study, “Spectral mapping reveals a resemblance of the anesthetic brain state to both sleep and coma,” reveals that being anesthetized may be more than simply being “put to sleep.” It can potentially carry more similarities to being in a coma than we originally thought.

A new approach to cancer vaccination yields more powerful T cells

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the T-cell response with a new type of vaccine adjuvant (a material that can help stimulate the immune system). The new adjuvant consists of mRNA molecules encoding genes that turn on immune signaling pathways and promote a supercharged T-cell response.

In studies in mice, this mRNA-encoded adjuvant enabled the immune system to completely eradicate most tumors, either on its own or delivered along with a tumor antigen. The adjuvant also boosted the T-cell response to vaccines against influenza and COVID-19.

Pharmacological strategies targeting hepatocyte-mediated crosstalk in liver fibrosis

Liver fibrosis is a common pathological outcome of chronic liver injury. Many therapeutic agents show limited clinical efficacy or significant adverse effects due to the complex pathogenesis of liver fibrosis. This challenge underscores the urgent need to identify potential therapeutic targets and improve existing therapies. Hepatocytes serve as pivotal initiators of liver fibrosis that actively engage in signaling crosstalk with other hepatic cell types to promote fibrogenesis. Advances in understanding hepatocyte-centered signaling crosstalk have enabled the identification of potential therapeutic targets. Furthermore, combination therapies that regulate multiple pathways and drug modifications that improve pharmacological properties may help to minimize adverse effects and enhance the efficacy of existing treatments.

Regulation of neuronal invasion of small cell lung cancer by STMN2/β-alanine-controlled metabolic reprogramming

Zhou et al. demonstrate that perineural invasion (PNI) is an adverse prognostic factor in small cell lung cancer. They identify a neuron-STMN2-β-alanine axis, where the neural microenvironment upregulates STMN2 in tumor cells, reprogramming β-alanine metabolism to enhance cell migration and drive neural invasion, revealing a potential therapeutic target.

Neurotransmitter-activated GPCR signaling in myelin plasticity

Myelination is increasingly recognized as a dynamic and adaptive process regulated by oligodendrocytes throughout life. Beyond providing electrical insulation, myelin supports axonal metabolism and may serve as an energy reservoir under metabolic stress, highlighting the importance of physiological myelin turnover. Dysregulation of myelin dynamics contributes to a wide spectrum of neurological disorders, including demyelinating, neurodegenerative, and neuropsychiatric diseases. Growing evidence indicates that neurotransmitter signaling through G protein-coupled receptors (GPCRs) expressed by oligodendrocyte lineage cells regulates myelin formation, remodeling, and repair.

Gut microbiota-derived deoxycholic acid shapes an immunosuppressive tumor microenvironment and promotes breast cancer progression

Li et al. identify deoxycholic acid as a microbiota-derived driver of breast cancer progression. Deoxycholic acid activates farnesoid X receptor signaling to induce interleukin-6 production, promoting immunosuppressive cell recruitment and establishing a metabolite-driven immune regulatory axis with therapeutic potential.

Giving X-ray vision a sense of direction

Whether in tooth enamel or in nanomaterials made of silicon, the orientation of tiny internal structures often determines the properties of a material. A new X-ray method can even make this nano-order visible when the structures are actually too small to be imaged directly. The method was developed by an international team led by the Helmholtz Center Hereon, and it opens up new possibilities to investigate materials and biological structures. The research is published in the journal Light: Science & Applications.

In medical X-ray imaging, the picture is created by the varying attenuation of X-rays in the body. In order to examine materials or biological tissue in detail, experts use advanced techniques that provide additional information, such as dark-field imaging. This technique exploits the fact that X-rays are scattered, i.e., deflected, at internal interfaces and irregularities. “The scattering reveals a lot about internal structures that are not directly visible in the actual image,” explains Hereon researcher Sami Wirtensohn, first author of the study.

To make these fine structures visible, the dark field method blocks the direct X-ray beam. This allows the detector to capture only the radiation scattered inside the sample. Until now, this method has only been able to show that such structures exist, but not how they are spatially aligned.

Emerging Osteoarthritis Treatment Involves Electrically Stimulating Muscles

An estimated 595 million people globally are living with osteoarthritis. This makes it one of the leading causes of pain and disability.

Osteoarthritis is a degenerative joint disease, in which tissues in the joint break down over time. The condition can affect any joint, but most commonly the knees, hips, hands and spine.

However, the impact of osteoarthritis often goes beyond the affected joint. The condition can have profound effects on daily life.

Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers

This Review provides an integrated overview of Kupffer cell biology, from their embryonic origin and spatial organization to their functional specialization within the liver. It emphasizes how Kupffer cells act as immune sentinels while also shaping metabolic regulation, tissue repair, infection and cancer and discusses how emerging technologies are refining our understanding of their context-dependent roles across physiological and pathological settings.

/* */